Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label Study to Assess the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Povetacicept in Subjects With Autoimmune Cytopenias (RUBY-4)

NCT05757570 is registered in ClinicalTrials.gov with Alpine Immune Sciences Inc, A Subsidiary of Vertex as lead sponsor.

NCT NCT05757570
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05757570 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label Study to Assess the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Povetacicept in Subjects With Autoimmune Cytopenias (RUBY-4)
Lead sponsor
Alpine Immune Sciences Inc, A Subsidiary of Vertex
Phase
Phase 1/2
Overall status
Completed
Start date
July 3, 2023
Completion date
August 12, 2026
Enrollment
30 (actual)
Sites
44

Conditions

As the registry lists them; a condition with its own page is linked.

cold agglutinin disease, idiopathic thrombocytopenic purpura, immune thrombocytopenia, warm autoimmune hemolytic anemia